Newsroom
Press Releases
05/11/25 - 17:46
Price sensitiveDiasorin’s Board of Directors approves results for the first 9 months of 2025. FY 2025 Guidance revised
Financial Data
31/10/25 - 10:12
Diasorin receives 510(k) clearance for Simplexa COVID-19, Flu A/B & RSV Direct kit on the LIAISON MDX from the U.S. Food and Drug Administration
Products
Molecular